secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxart, Inc. (VXRT)
CIK:        0000072444
Form:       8-K
Filed at:   2026-10-19T20:06:47+00:00
Accession:  0001437749-26-032932
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Vaxart Appoints Dr. Raquel Bono to Board of Directors
-----------------------------------------------------

- Raquel C. Bono, M.D., retired U.S. Navy Vice Admiral, was appointed to Vaxart's board effective Oct. 16, 2026; the board deemed her independent.
- Bono led the Defense Health Agency from 2015 to 2019, overseeing a $50 billion global healthcare system serving 9.5 million beneficiaries.
- She was appointed under Vaxart's July 2026 cooperation agreement with stockholders and will chair the Stockholder Engagement Committee.
- Bono is a Humana (NYSE: HUM) director and served as Chief Health Officer of Viking Cruises (NYSE: VIK) from November 2020 to December 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72444/000143774926032932/0001437749-26-032932-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72444/000143774926032932/vxrt20261016_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-032932

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer